This finding is consistent with that of a previous study, which analyzed 2-HG in 89 glioma patients who received radiotherapy and chemotherapy and found that the 2-HG level in the IDH-mutated genotype was gradually decreased, suggesting that the treatment was effective and that the prognosis was better [71]. Here, IDH2 is linked to central nervous system cancer.